Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platform

Special Report: Australian biotech company Prescient Therapeutics (ASX:PTX) has announced what’s next for its next-generation gene therapy technology for fighting … Read More

The post Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platform appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *